FDA — authorised 7 October 2019
- Application: BLA761125
- Marketing authorisation holder: NOVARTIS PHARMS CORP
- Status: approved
FDA authorised Beovu on 7 October 2019
Yes. FDA authorised it on 7 October 2019; FDA has authorised it.
NOVARTIS PHARMS CORP holds the US marketing authorisation.